NeuroScientific Biopharmaceuticals Secures $3.7m tax incentive refund
NeuroScientific Biopharmaceuticals (NSB) pockets a $3.7 million tax refund from the Australian Federal Government.
The company received...
NeuroScientific Biopharmaceuticals Appoints Paul Rennie as interim CEO
NeuroScientific Biopharmaceuticals (NSB) appoints Paul Rennie as interim CEO, nearly three months after former CEO Matt...
